A phase 3 study of the effect of denosumab therapy on bone mineral density in women receiving aromatase inhibitors for non metastatic breast cancer

被引：0
|
作者：
Ellis, G.
Bone, H. G.
Chlebowski, R.
Paul, D.
Spadafora, S.
Smith, J.
Fan, M.
Jun, S.
机构：
[1] Seattle Canc Care Alliance, Seattle, WA USA
[2] Michigan Bone & Mineral Clin, Detroit, MI USA
[3] UCLA Med Ctr, Torrance, CA USA
[4] Rocky Mt Canc Ctr, Denver, CO USA
[5] Algoma Reg Canc Program, Saulte Ste Marie, ON, Canada
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2008年 / 109卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [31] Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05): : 875 - 884
  • [32] Impact of adjuvant aromatase inhibitors on bone mineral density in breast cancer patients
    Lai, C. N.
    Correa, P. D.
    Alhasso, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Bone mineral density change on aromatase inhibitors as a predictor of breast cancer recurrence
    Martin, Hilary L.
    Davidson, John A.
    Yap, Francis
    Chung, Kim
    Khattak, Muhammad A.
    Redfern, Andrew D.
    CANCER RESEARCH, 2015, 75
  • [34] Effect of denosumab on low bone mineral density in postmenopausal Japanese early breast cancer patients receiving aromatase nhibitors: 36-month results
    Sakaguchi, K.
    Nakatsukasa, K.
    Koyama, H.
    Matsuda, T.
    Kato, M.
    Ouchi, Y.
    Morita, M.
    Taguchi, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 69 - 69
  • [35] Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study
    Rossini, Alessandro
    Frigerio, Sofia
    Dozio, Elena
    Trevisan, Roberto
    Perseghin, Gianluca
    Corbetta, Sabrina
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [36] Aromatase Inhibitors and Mammographic Breast Density in Postmenopausal Women Receiving Estrogen Progestin Therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1219 - 1220
  • [37] BONE MINERAL DENSITY AND BODY MASS INDEX IN 209 CONSECUTIVE PATIENTS COMMENCING OR RECEIVING AROMATASE INHIBITORS FOR BREAST CANCER
    Sheldon, P.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S496 - S497
  • [38] The Effect of Exercise on Body Composition and Bone Mineral Density in Breast Cancer Survivors Taking Aromatase Inhibitors
    Thomas, Gwendolyn A.
    Cartmel, Brenda
    Harrigan, Maura
    Fiellin, Martha
    Capozza, Scott
    Zhou, Yang
    Ercolano, Elizabeth
    Gross, Cary P.
    Hershman, Dawn
    Ligibel, Jennifer
    Schmitz, Kathryn
    Li, Fang-Yong
    Sanft, Tara
    Irwin, Melinda L.
    OBESITY, 2017, 25 (02) : 346 - 351
  • [39] Effects of Aromatase inhibitors on bone mineral density and trabecular bone score in patients with breast cancer
    Dabbagh, V.
    Shandiz, F. Homaee
    Kermani, A. Taghizadeh
    Javan, F. Nesari
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S465 - S465
  • [40] EFFECT OF ADJUVANT THERAPY ON BONE MINERAL DENSITY IN CAUCASIAN WOMEN WITH BREAST CANCER
    Tsagareli, M.
    Giorgadze, E.
    Khachidze, N.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S228 - S229
12345